Cleared Traditional

K071391 - PHILIPS HEARTSTART 12 LEAD TRANSFER STA...

K071391 is the FDA 510(k) clearance for PHILIPS HEARTSTART 12 LEAD TRANSFER STA... by Philips Medical Systems, Inc.. It is a Class 2 Cardiovascular device (product code MSX) cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K071391 · Philips Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2007
Decision
112d
Days
Class 2
Risk

K071391 is an FDA 510(k) clearance for the PHILIPS HEARTSTART 12 LEAD TRANSFER STATION, MODEL 989803142521. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Philips Medical Systems, Inc. (Andover, US). The FDA issued a Cleared decision on September 7, 2007 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medical Systems, Inc. devices

Submission Details

510(k) Number K071391 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 2007
Decision Date September 07, 2007
Days to Decision 112 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 125d · This submission: 112d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 73
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K071391.
INTELLISPHERE EVENT MANAGMENT SYSTEM REL. 10.00
K102974 · Philips Medical Systems · Jan 2011
PHILIPS TELEMEDICINE SERVER/SYSTEM, MODEL 861441
K091176 · Philips Medical Systems · Nov 2009
HYPERVISOR VI CENTRAL MONITORING SYSTEM (INCLUDING TMS)
K080192 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2008
MASIMO PATIENT SAFETY NET
K071047 · Masimo Corporation · Jun 2007
DATEX-OHMEDA S/5 DEVICE INTERFACING SOLUTION, N-DISXXXX..01 WITH N-DISVENT..02
K070421 · Ge Healthcare · Mar 2007
PMP4 APPLICATION
K061428 · Card Guard Scientific Survival , Ltd. · Oct 2006